NanoString Technologies Gets $15.3M

Seattle-based NanoString Technologies, which develops life science tools for the molecular diagnostics area, said this morning that it has raised $15.3M in a Series E funding round. The round came from Morgan Stanley Expansion Capital and AllianceBernstein Alternative Investment Management Group, as well as all of its prior investors, including Clarus Ventures, Draper Fisher Jurvetson, OVP Venture Partners, GE healthymagination Fund, BioMed Ventures, and Henri Termeer. NanoString said the funding will go towards the expansion of its existing business, plus the launch of its products in the molecular diagnostics area.